Acknowledgements, Vaccine Pre-clinical Toxicology Testing, NIAID Division of HIV Vaccine Site

Vaccine Pre-clinical Toxicology Testing

Vaccine Designs/Concepts

Correlates of Immunity

Assay Development

Animal Models

Immunologic Adjuvants

Variation

International Studies

Behavior

Ethics

Vaccine Design and Methodologic Issues

Assay Validation

Vaccine Pre-clinical Toxicology Testing

Previous - Glossary | Next - About the authors

Acknowledgements

The authors would like to acknowledge critical review by Drs. Karen Midthun (CBER/OVRR) and James Bradac (NIH/NIAID/DAIDS). We would also like to kindly acknowledge the expert and lightening-fast web interface advice of LCDR Sylvia Tetzlaff, USPHS (CBER/OVRR/DVRPA).

Last updated February 13, 2003 (rjt)